BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 22878649)

  • 1. MicroRNA expression profiles associated with pancreatic adenocarcinoma and ampullary adenocarcinoma.
    Schultz NA; Werner J; Willenbrock H; Roslind A; Giese N; Horn T; Wøjdemann M; Johansen JS
    Mod Pathol; 2012 Dec; 25(12):1609-22. PubMed ID: 22878649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detecting and diagnosing ampullary neoplasms.
    Wang LF; Hingorani SR; Tuveson DA
    Cancer Biol Ther; 2004 Jul; 3(7):657-9. PubMed ID: 15326385
    [No Abstract]   [Full Text] [Related]  

  • 3. Gene expression profiling identifies markers of ampullary adenocarcinoma.
    Van Heek NT; Maitra A; Koopmann J; Fedarko N; Jain A; Rahman A; Iacobuzio-Donahue CA; Adsay V; Ashfaq R; Yeo CJ; Cameron JL; Offerhaus JA; Hruban RH; Berg KD; Goggins M
    Cancer Biol Ther; 2004 Jul; 3(7):651-6. PubMed ID: 15136764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical staining in the diagnosis of pancreatobiliary and ampulla of Vater adenocarcinoma: application of CDX2, CK17, MUC1, and MUC2.
    Chu PG; Schwarz RE; Lau SK; Yen Y; Weiss LM
    Am J Surg Pathol; 2005 Mar; 29(3):359-67. PubMed ID: 15725805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-215 overexpression distinguishes ampullary carcinomas from pancreatic carcinomas.
    Choi DH; Park SJ; Kim HK
    Hepatobiliary Pancreat Dis Int; 2015 Jun; 14(3):325-9. PubMed ID: 26063036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene Expression of Col11A1 Is a Marker Not only for Pancreas Carcinoma But also for Adenocarcinoma of the Papilla of Vater, Discriminating Between Carcinoma and Chronic Pancreatitis.
    Kleinert R; Prenzel K; Stoecklein N; Alakus H; Bollschweiler E; Hölscher A; Warnecke-Eberz U
    Anticancer Res; 2015 Nov; 35(11):6153-8. PubMed ID: 26504042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-21, miR-34a, miR-198 and miR-217 as diagnostic and prognostic biomarkers for chronic pancreatitis and pancreatic ductal adenocarcinoma.
    Vychytilova-Faltejskova P; Kiss I; Klusova S; Hlavsa J; Prochazka V; Kala Z; Mazanec J; Hausnerova J; Kren L; Hermanova M; Lenz J; Karasek P; Vyzula R; Slaby O
    Diagn Pathol; 2015 Apr; 10():38. PubMed ID: 25908274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue MicroRNA profiles as diagnostic and prognostic biomarkers in patients with resectable pancreatic ductal adenocarcinoma and periampullary cancers.
    Calatayud D; Dehlendorff C; Boisen MK; Hasselby JP; Schultz NA; Werner J; Immervoll H; Molven A; Hansen CP; Johansen JS
    Biomark Res; 2017; 5():8. PubMed ID: 28239461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-ampullary-duodenal carcinomas: clinicopathologic analysis of 47 cases and comparison with ampullary and pancreatic adenocarcinomas.
    Xue Y; Vanoli A; Balci S; Reid MM; Saka B; Bagci P; Memis B; Choi H; Ohike N; Tajiri T; Muraki T; Quigley B; El-Rayes BF; Shaib W; Kooby D; Sarmiento J; Maithel SK; Knight JH; Goodman M; Krasinskas AM; Adsay V
    Mod Pathol; 2017 Feb; 30(2):255-266. PubMed ID: 27739441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrapancreatic distal common bile duct carcinoma: Analysis, staging considerations, and comparison with pancreatic ductal and ampullary adenocarcinomas.
    Gonzalez RS; Bagci P; Basturk O; Reid MD; Balci S; Knight JH; Kong SY; Memis B; Jang KT; Ohike N; Tajiri T; Bandyopadhyay S; Krasinskas AM; Kim GE; Cheng JD; Adsay NV
    Mod Pathol; 2016 Nov; 29(11):1358-1369. PubMed ID: 27469329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-21 up-regulation in ampullary adenocarcinoma and its pre-invasive lesions.
    Saraggi D; Galuppini F; Fanelli GN; Remo A; Urso EDL; Bao RQ; Bacchin D; Guzzardo V; Luchini C; Braconi C; Farinati F; Rugge M; Fassan M
    Pathol Res Pract; 2018 Jun; 214(6):835-839. PubMed ID: 29731265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular signatures of mRNAs and miRNAs as prognostic biomarkers in pancreatobiliary and intestinal types of periampullary adenocarcinomas.
    Sandhu V; Bowitz Lothe IM; Labori KJ; Lingjærde OC; Buanes T; Dalsgaard AM; Skrede ML; Hamfjord J; Haaland T; Eide TJ; Børresen-Dale AL; Ikdahl T; Kure EH
    Mol Oncol; 2015 Apr; 9(4):758-71. PubMed ID: 25579086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Support Vector Machine Based on microRNA Expression Profiles to Predict Histological Origin of Ampullary Carcinoma: Case Report of a Patient Affected From Adenocarcinoma of the Papilla of Vater With Lynch Syndrome.
    Tavano F; Copetti M; Piepoli A; Carella M; Gentile A; Burbaci FP; Fontana A; De Bonis A; di Mola FF; di Sebastiano P; Andriulli A
    Pancreas; 2016 Apr; 45(4):626-9. PubMed ID: 26954494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential expression of miRNAs in pancreatobiliary type of periampullary adenocarcinoma and its associated stroma.
    Sandhu V; Bowitz Lothe IM; Labori KJ; Skrede ML; Hamfjord J; Dalsgaard AM; Buanes T; Dube G; Kale MM; Sawant S; Kulkarni-Kale U; Børresen-Dale AL; Lingjærde OC; Kure EH
    Mol Oncol; 2016 Feb; 10(2):303-16. PubMed ID: 26590090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-196b is an independent prognostic biomarker in patients with pancreatic cancer.
    Kanno S; Nosho K; Ishigami K; Yamamoto I; Koide H; Kurihara H; Mitsuhashi K; Shitani M; Motoya M; Sasaki S; Tanuma T; Maguchi H; Hasegawa T; Kimura Y; Takemasa I; Shinomura Y; Nakase H
    Carcinogenesis; 2017 Apr; 38(4):425-431. PubMed ID: 28186267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidermal growth factor receptor signaling pathway is frequently altered in ampullary carcinoma at protein and genetic levels.
    Mikhitarian K; Pollen M; Zhao Z; Shyr Y; Merchant NB; Parikh A; Revetta F; Washington MK; Vnencak-Jones C; Shi C
    Mod Pathol; 2014 May; 27(5):665-74. PubMed ID: 24186143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Global microRNA expression profiling of microdissected tissues identifies miR-135b as a novel biomarker for pancreatic ductal adenocarcinoma.
    Munding JB; Adai AT; Maghnouj A; Urbanik A; Zöllner H; Liffers ST; Chromik AM; Uhl W; Szafranska-Schwarzbach AE; Tannapfel A; Hahn SA
    Int J Cancer; 2012 Jul; 131(2):E86-95. PubMed ID: 21953293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. K-ras mutations in the duodenal fluid of patients with pancreatic carcinoma.
    Wilentz RE; Chung CH; Sturm PD; Musler A; Sohn TA; Offerhaus GJ; Yeo CJ; Hruban RH; Slebos RJ
    Cancer; 1998 Jan; 82(1):96-103. PubMed ID: 9428484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of p16 protein and cyclin D1 in periampullary carcinomas.
    Tuncer E; Türk NS; Arici S; Düzcan SE; Demirkan NC
    Turk Patoloji Derg; 2011 Jan; 27(1):17-22. PubMed ID: 21469422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ep-CAM expression in pancreatic and ampullary carcinomas: frequency and prognostic relevance.
    Fong D; Steurer M; Obrist P; Barbieri V; Margreiter R; Amberger A; Laimer K; Gastl G; Tzankov A; Spizzo G
    J Clin Pathol; 2008 Jan; 61(1):31-5. PubMed ID: 16775119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.